Introduction

The new FIP Development Goals which have just launched are set to transform global pharmacy by providing a systematic and integrated framework that can support the transformation of pharmacy practice, science and workforce & education. Of the 21 Goals, FIP Development Goal 10 impacts us all. The Equity & Equality Goal calls for clear strategies to address inequalities in the pharmaceutical workforce, widen access and equity of pharmaceutical care services & access, as well equity in global capacity in pharmaceutical sciences development. Together we will deconstruct Goal 10 for pharmacy, discuss ways we can implement them and how FIP-EquityRx (FIP’s programme on Equity & Equality) is supporting FIP DG 10’s global implementation.

Together we will explore the following questions… and so much more! 

1. What is FIP Development Goal 10 and how it came to be? How will FIP-EquityRx drive this Goal? FIP’s Catherine Duggan & Lina Bader will showcase the birth of FIP DG10… and our plans to tackle global priorities through FIP EquityRx
2. How FIP DG 10 fits within the global quest for equity in health, women in health and access to quality care? What more should pharmacy do? We will hear from – and be challenged by – Roopa Dhatt (Executive Director, Women in Global Health)…
3. What is the impact of inequities to access to medicines & pharmaceutical care on lives and nations? Through a regional lens, Adi Nuseirat (Technical Officer, World Health Organization) shows us the realities in the Eastern Mediterranean region..
4. Why we need equity in pharmacy now! FIP’s ex-President Carmen Peña calls on all of us to amp up the action…
5. What does equity in pharmacy (workforce, practice and science) REALLY MEAN? We will explore this question & more through a virtual roundtable with panelists from around the world including Claire Thompson, Nilhan Uzman, Nadia Bukhari, Vibhuti Arya, and Shane Desselle, Angie Lim Hui Li, Isaac Nii Ofoli Anang, Sherly Meilianti & many more joining us on the day!

This Roundtable will be moderated by FIP CEO Catherine Duggan and Lead for FIP-EquityRx Lina Bader. Please join us!